This study is in progress, not accepting new patients
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
a study on Solid Tumor
Solid Tumor PD1 PD-1 PDL1 PD-L1 Neoplasms Pembrolizumab
Lead Scientist at UCSF
- Hope Rugo
Dr. Hope Rugo is a medical oncologist and hematologist specializing in breast cancer research and treatment. A Clinical Professor of Medicine, Dr. Rugo joined the Breast Care Center in 1999 after a decade of experience at UCSF in malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Merck Sharp & Dohme Corp.
- Phase 1
- Study Type
- Last Updated